SCHEMBL2444898

SCHEMBL2444898

C[C@H]1CN(CCCO)C[C@H](C)N1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
SCARB1 Q8WTV0 2/20 0.47
ALDH1A1 P00352 1/20 0.47
TP53 P04637 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
MAPK1 P28482 1/20 0.47
CYP2C19 P33261 1/20 0.47
HTR2B P41595 1/20 0.47
HTT P42858 1/20 0.47
KDM4E B2RXH2 1/20 0.45
GBA1 P04062 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2384684 1.00 SIGMAR1 (0.47) SIGMAR1MEN1KMT2ASCARB1ALDH1A1
SCHEMBL2386357 1.00 SIGMAR1 (0.47) SIGMAR1MEN1KMT2ASCARB1ALDH1A1
Hydrochloric Acid SCHEMBL7409404 0.98 MEN1 (0.47) SIGMAR1MEN1KMT2ASCARB1ALDH1A1
SCHEMBL2349160 0.86 SIGMAR1 (0.42) SIGMAR1MEN1KMT2ASCARB1ALDH1A1
SCHEMBL3103478 0.80 GLB1 (0.52) SIGMAR1MEN1KMT2ASCARB1ALDH1A1
SCHEMBL2386353 0.78 SIGMAR1 (0.47) SIGMAR1MEN1KMT2ASCARB1ALDH1A1
SCHEMBL2387295 0.78 SIGMAR1 (0.47) SIGMAR1MEN1KMT2ASCARB1ALDH1A1
SCHEMBL10921394 0.78 SIGMAR1 (0.47) SIGMAR1MEN1KMT2ASCARB1ALDH1A1
SCHEMBL3106230 0.78 SIGMAR1 (0.57) SIGMAR1MEN1KMT2ASCARB1ALDH1A1
SCHEMBL3965353 0.78 SIGMAR1 (0.47) SIGMAR1MEN1KMT2ASCARB1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2215085-B1 PYRIDINE AND PYRAZINE DERIVATIVES USEFUL IN THE TREATMENT OF CELL PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2011-09-07 EP disclosed